Table 2.
Baseline characteristics and hematologic findings of patients with severe COVID-19.
| Severe (ICU & Death) | ICU | Death | P Value | |
|---|---|---|---|---|
| N (%); Mean (±SD) | N (%); Mean (±SD) | N (%); Mean (±SD) | ||
| Baseline features | ||||
| Sample size | 243 (100) | 59 (24.3%) | 184 (75.7%) | |
| Age (Year) | 66.47 (±17.70) | 56.03 (±18.84) | 69.82 (±15.98) | 0.000 |
| ≤ 39 | 19/243 (7.8) | 14/59 (23.7) | 5/184 (2.7) | 0.000 |
| 40–49 | 20/243 (8.2) | 8/59 (13.6) | 12/184 (6.5) | |
| 50–59 | 32/243 (13.2) | 9/59 (15.3) | 23/184 (12.5) | |
| 60–69 | 46/243 (18.9) | 11/59 (18.6) | 35/184 (19) | |
| ≥ 70 | 126/243 (51.9) | 17/59 (28.8) | 109/184 (59.2) | |
| Sex | ||||
| Female | 102 (42) | 28 (47.5) | 74 (40.2) | 0.327 |
| Male | 141 (58) | 31 (52.5) | 110 (59.8) | |
| Systolic BP | 120.1 (±26.22) | 123.5 (±22.78) | 118.96 (±27.23) | 0.241 |
| Diastolic BP | 74.1 (±13.25) | 76.74 (±11.04) | 73.21 (±13.87) | 0.078 |
| Heart rate | 92.4 (±20.51) | 90.5 (±17.60) | 93.0 (±21.41) | 0.371 |
| Respiratory rate | 20.4 (±6.24) | 18.88 (±4.85) | 20.9 (±6.57) | 0.018 |
| Temperature | 37.2 (±0.81) | 37.2 (±0.76) | 37.2 (±0.83) | 0.920 |
| Hospitalization (Day) | 8.16 (±11.03) | 10.91 (±9.67) | 7.27 (±11.31) | 0.027 |
| Hematologic findings | ||||
| WBC count | 9.74 (±6.23) | 6.78 (±3.42) | 10.80 (±6.66) | 0.000 |
| < 3.5 | 10% | 15.5% | 8% | 0.000 |
| > 11 | 34.1% | 12.1% | 42% | |
| Neutrophil count | 8.16 (±5.50) | 5.42 (±3.13) | 9.15 (±5.83) | 0.000 |
| < 1.8 | 3% | 7.5% | 1.4% | 0.000 |
| > 6.3 | 54.8% | 26.4% | 65.1% | |
| Lymphocyte count* | 1.05 (0.72–1.49) | 1.12 (0.75–1.54) | 1.05 (0.70–1.40) | 0.808 |
| < 1.1 | 54% | 48.1% | 56.1% | 0.317 |
| Neu/Lymph ratio | 8.17 (±5.96) | 5.30 (±4.42) | 9.23 (±6.12) | 0.000 |
*:
Median (IQR); BP: Blood pressure; WBC: White blood cell; Neu: Neutrophil; Lymph: Lymphocyte.